AngioDynamics Historical Balance Sheet
ANGO Stock | USD 6.32 0.46 7.85% |
Trend analysis of AngioDynamics balance sheet accounts such as Total Assets of 533.4 M, Short and Long Term Debt Total of 66.3 M or Other Current Liab of 52.4 M provides information on AngioDynamics' total assets, liabilities, and equity, which is the actual value of AngioDynamics to its prevalent stockholders. By breaking down trends over time using AngioDynamics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining AngioDynamics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AngioDynamics is a good buy for the upcoming year.
AngioDynamics Inventory |
|
AngioDynamics |
About AngioDynamics Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of AngioDynamics at a specified time, usually calculated after every quarter, six months, or one year. AngioDynamics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of AngioDynamics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which AngioDynamics currently owns. An asset can also be divided into two categories, current and non-current.
AngioDynamics Balance Sheet Chart
AngioDynamics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how AngioDynamics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, AngioDynamics' Other Current Assets are very stable compared to the past year. As of the 24th of May 2024, Non Currrent Assets Other is likely to grow to about 65.6 M, while Common Stock Shares Outstanding is likely to drop about 29.4 M. Add Fundamental
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Assets
Total assets refers to the total amount of AngioDynamics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AngioDynamics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Additional Paid In Capital
Additional Paid In Capital (or APIC) is an accounting term found on AngioDynamics Balance Sheet under Shareholders Equity. It is the value of the shares of the company above what they were issued it. The basic calculation is as follow: (Issue Price - Par Value) x AngioDynamics Shares Outstanding. Additional Paid In Capital is not affected by secondary trading of AngioDynamics shares and does not have any impact on the value of APIC. The excess amount paid by investors over the par value of a company’s shares, representing the additional capital contributed by shareholders.Most accounts from AngioDynamics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into AngioDynamics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.At this time, AngioDynamics' Other Current Assets are very stable compared to the past year. As of the 24th of May 2024, Non Currrent Assets Other is likely to grow to about 65.6 M, while Common Stock Shares Outstanding is likely to drop about 29.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 33.8M | 49.8M | 57.3M | 66.3M | Total Assets | 552.8M | 532.6M | 612.5M | 533.4M |
AngioDynamics balance sheet Correlations
Click cells to compare fundamentals
AngioDynamics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AngioDynamics balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 38.0M | 38.3M | 39.0M | 39.5M | 45.4M | 29.4M | |
Total Assets | 595.5M | 561.4M | 552.8M | 532.6M | 612.5M | 533.4M | |
Short Long Term Debt Total | 40.8M | 20M | 33.8M | 49.8M | 57.3M | 66.3M | |
Other Current Liab | 2.1M | 38.0M | 21.5M | 43.4M | 49.9M | 52.4M | |
Total Current Liabilities | 51.5M | 57.6M | 74.3M | 83.8M | 96.4M | 48.7M | |
Total Stockholder Equity | 455.9M | 439.5M | 424.5M | 378.3M | 435.0M | 404.2M | |
Property Plant And Equipment Net | 28.3M | 37.1M | 45.0M | 44.4M | 51.0M | 35.0M | |
Net Debt | (13.6M) | (28.2M) | 5.0M | 5.2M | 6.0M | 5.7M | |
Retained Earnings | (100.3M) | (131.9M) | (158.4M) | (210.9M) | (189.8M) | (180.3M) | |
Accounts Payable | 19.1M | 19.6M | 28.0M | 40.4M | 46.5M | 48.8M | |
Cash | 54.4M | 48.2M | 28.8M | 44.6M | 51.3M | 45.7M | |
Non Current Assets Total | 442.6M | 420.6M | 409.4M | 369.1M | 424.5M | 382.2M | |
Other Assets | 5.2M | 3.8M | 11.0M | 49.2M | 56.6M | 59.4M | |
Long Term Debt | 40M | 20M | 25M | 49.8M | 57.3M | 58.7M | |
Cash And Short Term Investments | 54.4M | 48.2M | 28.8M | 44.6M | 51.3M | 61.7M | |
Net Receivables | 31.3M | 35.4M | 52.3M | 52.8M | 60.7M | 38.3M | |
Common Stock Total Equity | 374K | 377K | 380K | 382K | 439.3K | 308.9K | |
Liabilities And Stockholders Equity | 595.5M | 561.4M | 552.8M | 532.6M | 612.5M | 533.4M | |
Non Current Liabilities Total | 88.1M | 64.4M | 53.9M | 70.5M | 81.1M | 80.5M | |
Inventory | 59.9M | 48.6M | 51.4M | 55.3M | 63.6M | 42.5M | |
Other Current Assets | 2.2M | 1.8M | 2.2M | 4.6M | 4.2M | 4.5M | |
Other Stockholder Equity | 557.2M | 567.8M | 581.2M | 593.5M | 682.5M | 424.4M | |
Total Liab | 139.6M | 122.0M | 128.3M | 154.3M | 177.5M | 129.1M | |
Property Plant And Equipment Gross | 28.3M | 37.1M | 96.1M | 44.4M | 51.0M | 37.5M | |
Total Current Assets | 152.9M | 140.9M | 143.3M | 163.5M | 188.1M | 151.2M | |
Accumulated Other Comprehensive Income | (1.3M) | 3.2M | 1.4M | (4.7M) | (5.4M) | (5.2M) | |
Short Term Debt | 836K | 2.4M | 8.8M | 14.8M | 17.0M | 8.5M | |
Intangible Assets | 197.1M | 169.0M | 152.4M | 111.1M | 127.8M | 113.3M | |
Common Stock | 374K | 377K | 380K | 382K | 439.3K | 309.7K | |
Property Plant Equipment | 28.3M | 37.1M | 45.0M | 44.4M | 51.0M | 34.9M | |
Non Currrent Assets Other | 15.6M | 13.2M | (5.1M) | 54.3M | 62.5M | 65.6M | |
Other Liab | 39.6M | 37.1M | 24.2M | 17.4M | 20.0M | 32.6M | |
Good Will | 201.5M | 201.3M | 201.1M | 159.2M | 183.1M | 283.9M | |
Net Tangible Assets | 57.2M | 69.2M | 71.1M | 378.3M | 435.0M | 456.8M | |
Retained Earnings Total Equity | (100.3M) | (131.9M) | (158.4M) | (210.9M) | (189.8M) | (180.3M) | |
Long Term Debt Total | 40M | 20M | 25M | 49.8M | 44.8M | 69.2M | |
Capital Surpluse | 561.9M | 573.5M | 586.9M | 599.2M | 689.1M | 600.4M | |
Deferred Long Term Liab | 24.1M | 20.0M | 16.0M | 12.8M | 14.7M | 14.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for AngioDynamics Stock analysis
When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Transaction History View history of all your transactions and understand their impact on performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.80) | Revenue Per Share 8.105 | Quarterly Revenue Growth (0.07) | Return On Assets (0.05) | Return On Equity (0.62) |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.